申请人:HOLDER Swen
公开号:US20090156604A1
公开(公告)日:2009-06-18
Compounds of formula (I)
a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.
式(I)的化合物或其互变异构体或立体异构体,或其盐,其中环B和其融合的咪唑环,R4,R6和R7的含义如描述和权利要求中所述,是Pi3K/Akt途径的有效抑制剂。